ArticleBlood advances2026

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.